Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf
QXR
0.005
66.7%
LSR
0.01
-44.4%
CZN
0.003
50%
SRH
0.11
-37.1%
MHC
0.025
47.1%
PAB
0.002
-33.3%
DTM
0.004
33.3%
DY6
0.094
-30.4%
HCT
0.057
32.6%
FGH
0.008
-27.3%
ANX
0.009
28.6%
ENV
0.007
-22.2%
TYX
0.005
25%
BYH
0.004
-20%
BMR
0.18
24.1%
VHM
0.26
-20%
BPP
0.006
20%
ANR
0.005
-16.7%
EM2
0.006
20%
ERL
0.005
-16.7%
MSG
0.006
20%
BOT
0.39
-16.1%
EVS
0.085
19.7%
DAL
0.027
-15.6%
G88
0.013
18.2%
AN1
0.006
-14.3%
BNL
0.007
16.7%
ENL
0.033
-13.2%
CUF
0.007
16.7%
ATV
0.007
-12.5%
HHR
0.007
16.7%
WHK
0.014
-12.5%
IPT
0.007
16.7%
AUG
0.029
-12.1%
PVT
0.007
16.7%
GRV
0.046
-11.5%
VRX
0.066
15.8%
GSS
0.575
-11.5%
BKT
0.023
15%
SVG
0.023
-11.5%
